Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03435965
Other study ID # PROM by AmnioQuick Duo+
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2018
Est. completion date November 1, 2019

Study information

Verified date August 2019
Source Aljazeera Hospital
Contact Mahmoud Alalfy
Phone 01002611058
Email mahmoudalalfy@ymail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Preterm premature rupture of the membranes (PPROM) is responsible for one-third of all preterm births. Optimum treatment relies on accurate diagnosis and gestational age. The diagnosis of PPROM is made by a combination of examination, patient history and some simple tests.


Description:

Premature rupture of the fetal membranes (PROM) is the rupture of the amniotic membranes with release of the amniotic fluid prior to the onset of labour. PROM may be subdivided into term -PROM (TPROM, i.e. PROM after 37 weeks of gestation) and preterm PROM (PPROM, i.e. PROM prior to 37 weeks of gestation). PPROM occurs in approximately 3% of pregnancies and is responsible for a third of all preterm births.The diagnosis of PPROM is made by examination , patient history and simple testing. Patient history has an accuracy of 90% for the diagnosis of PPROM


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date November 1, 2019
Est. primary completion date October 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- pregnant ladies with PROM from 20- 37 weeks

Exclusion Criteria:

- Gestational Age >37 wks Non reassuring CTG Signs of chorioamnonitis ( Fever , maternal or fetal tachycardia , Foul cervical discharge , uterine tenderness or high TLC ) Antepartum hemorrhage

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
AmnioQuickDuo+
AmnioQuickDuo+ kit for detection of PROM

Locations

Country Name City State
Egypt Kasralainy Hospital Cairo
Egypt Algazeerah Giza

Sponsors (3)

Lead Sponsor Collaborator
Aljazeera Hospital Kasr El Aini Hospital, National Research Center, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of participants who was diagnosed with leakage of liqour by AmnioQuickDuo+ the accuracy of amnioQuick to diagnose PROM within a week
See also
  Status Clinical Trial Phase
Completed NCT01099280 - Induction of Labor in Term Premature Rupture of Membranes: A Comparison Between Oxytocin and Dinoprostone Followed Six Hours Later by Oxytocin Phase 3
Recruiting NCT05345457 - Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age Phase 4